Skip to main content
Clinical Trials/NL-OMON38803
NL-OMON38803
Completed
Not Applicable

Identification of mutated and non-mutated tumor-associated antigens in glioblastoma - GAPVAC (Glioma actively personalized vaccine consortium) part 1

Academisch Medisch Centrum0 sites5 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
glioblastoma
Sponsor
Academisch Medisch Centrum
Enrollment
5
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age: \>\= 18 years
  • Unresected primary or recurrent brain tumor
  • Haemoglobin \>\= 10 g/100 ml
  • Able to understand the research and give written informed consent

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials